The case for medical marijuana in epilepsy.
https://www.ncbi.nlm.nih.gov/pubmed/24854149
Cannabinoids for pain management.
https://www.ncbi.nlm.nih.gov/pubmed/21508629
Cannabinoids: new promising agents in the treatment of neurological diseases.
https://www.ncbi.nlm.nih.gov/pubmed/25407719
The endocannabinoid system in neurodegeneration.
https://www.ncbi.nlm.nih.gov/pubmed/17274532
The endocannabinoid system in targeting inflammatory neurodegenerative diseases (Multiple Sclerosis).
https://www.ncbi.nlm.nih.gov/pubmed/17350694
Marijuana-like chemicals inhibit human immunodeficiency virus (HIV) in late-state AIDS
https://www.sciencedaily.com/releases/2012/03/120320195252.htm
Alzheimer's disease; taking the edge off with cannabinoids?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190031/?tool=pubmed
Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH).
https://www.ncbi.nlm.nih.gov/pubmed/25778750
Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis.
https://www.ncbi.nlm.nih.gov/pubmed/21850403
The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy.
https://www.ncbi.nlm.nih.gov/pubmed/12954810
Endocannabinoids and Their Implications for Epilepsy.
https://www.ncbi.nlm.nih.gov/pubmed/9974182
Brain cannabinoid systems as targets for the therapy of neurological disorders.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819831/?tool=pubmed
Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo.
https://www.ncbi.nlm.nih.gov/pubmed/11164622
Cannabinoid receptors and pain.
https://www.ncbi.nlm.nih.gov/pubmed/11164622
The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
https://www.ncbi.nlm.nih.gov/pubmed/17890938
Role of cannabinoids in the treatment of pain and (painful) spasticity.
https://www.ncbi.nlm.nih.gov/pubmed/21142261
The role of endocannabinoids in pain modulation and the therapeutic potential of inhibiting their enzymatic degradation.
https://www.ncbi.nlm.nih.gov/pubmed/21466449
The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain.
https://www.ncbi.nlm.nih.gov/pubmed/11323130
Therapeutic potential of cannabinoid receptor agonists as analgesic agents.
https://www.ncbi.nlm.nih.gov/pubmed/16004597
The endocannabinoid system in neuropathological states.
https://www.ncbi.nlm.nih.gov/pubmed/19367511
The endocannabinoid system in neurodegeneration.
https://www.ncbi.nlm.nih.gov/pubmed/17274532
Cannabinoids and neuroprotection in motor-related disorders.
https://www.ncbi.nlm.nih.gov/pubmed/18220777
Multi-target-directed ligands in Alzheimer's disease treatment.
https://www.ncbi.nlm.nih.gov/pubmed/22050745
Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease.
https://www.ncbi.nlm.nih.gov/pubmed/24407485
Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy.
https://www.ncbi.nlm.nih.gov/pubmed/21475304
Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma.
https://www.ncbi.nlm.nih.gov/pubmed/17074588
Preclinical cancer trials with cannabinoids
http://www.cancer.gov/about-cancer/treatment/cam/patient/cannabis-pdq/#link/_13
Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells.
https://www.ncbi.nlm.nih.gov/pubmed/18025276
Cannabidiol, a Major Non-Psychotropic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts.
https://www.ncbi.nlm.nih.gov/pubmed/25801536
Rheumatologists lack confidence in their knowledge of cannabinoids pertaining to the management of rheumatic complaints.
https://www.ncbi.nlm.nih.gov/pubmed/25080153
-- Read: "Rheumatologists keep themselves ignorant by not keeping up with modern research in their field.